Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses
Background Bintrafusp alfa (BA) is a bifunctional fusion protein designed for colocalized, simultaneous inhibition of two immunosuppressive pathways, transforming growth factor-β (TGF-β) and programmed death-ligand 1 (PD-L1), within the tumor microenvironment (TME). We hypothesized that targeting PD...
Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
BMJ Publishing Group
2022-07-01
|
Cyfres: | Journal for ImmunoTherapy of Cancer |
Mynediad Ar-lein: | https://jitc.bmj.com/content/10/7/e004122.full |